These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 20100642

  • 1. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L, Benassi M, Arcangeli G, Bruzzaniti V, Giovinazzo G, Marucci L.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):269-76. PubMed ID: 20100642
    [Abstract] [Full Text] [Related]

  • 2. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G, Giovinazzo G, Benassi M, Marucci L.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1252-9. PubMed ID: 19251097
    [Abstract] [Full Text] [Related]

  • 3. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 4. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Tu WY, Kirwan J, Mendenhall WM.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1479-87. PubMed ID: 20934262
    [Abstract] [Full Text] [Related]

  • 5. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 6. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 7. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI, Chambers MS, Weber RS, Eisbruch A.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [Abstract] [Full Text] [Related]

  • 8. Long-term parotid gland function after radiotherapy.
    Braam PM, Roesink JM, Moerland MA, Raaijmakers CP, Schipper M, Terhaard CH.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):659-64. PubMed ID: 15936542
    [Abstract] [Full Text] [Related]

  • 9. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS, Weber RS, Garden AS.
    J Calif Dent Assoc; 2006 Sep 01; 34(9):743-8. PubMed ID: 17022299
    [Abstract] [Full Text] [Related]

  • 10. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.
    Radiother Oncol; 2006 Mar 01; 78(3):270-5. PubMed ID: 16564589
    [Abstract] [Full Text] [Related]

  • 11. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Kirwan J, Mendenhall WM.
    Laryngoscope; 2009 Oct 01; 119(10):1966-74. PubMed ID: 19688858
    [Abstract] [Full Text] [Related]

  • 12. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
    Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):445-53. PubMed ID: 16839705
    [Abstract] [Full Text] [Related]

  • 13. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA, Stavrev P, Parliament MB, Field C, Thompson H, Stavreva N, Fallone BG.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):178-85. PubMed ID: 15337554
    [Abstract] [Full Text] [Related]

  • 14. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 15. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Anzai Y, Marsh LH, Martel MK, Ten Haken RK, Wolf GT, Ship JA.
    Acta Otorhinolaryngol Belg; 1999 Jan 01; 53(3):271-5. PubMed ID: 10635407
    [Abstract] [Full Text] [Related]

  • 16. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten Haken RK, Eisbruch A, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1259-65. PubMed ID: 20005639
    [Abstract] [Full Text] [Related]

  • 17. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA.
    Radiother Oncol; 2005 Nov 15; 77(2):164-71. PubMed ID: 16256229
    [Abstract] [Full Text] [Related]

  • 18. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R, Kanji A, Parliament M, Warkentin H, Field C, Jha N, Hanson J.
    Am J Clin Oncol; 2007 Jun 15; 30(3):271-7. PubMed ID: 17551304
    [Abstract] [Full Text] [Related]

  • 19. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL, Chao KS, Haughey B.
    Semin Oncol; 2004 Dec 15; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA.
    Int J Radiat Oncol Biol Phys; 2001 Mar 15; 49(4):907-16. PubMed ID: 11240231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.